Remove people shin-kawamata-md-phd
article thumbnail

Why QbD and Digitalization Are Foundations for Cell Therapies

ISPE

An interview with Shin Kawamata of Japan’s Foundation for Biomedical Research and Innovation (FBRI) highlights exciting work to move cell therapy toward reliable and scalable commercialization. Shin Kawamata, MD, PhD. Pharmaceutical Engineering® recently spoke with Kawamata about his work.